Thesis (22 MB) - 
Free access
Highlights
Doctoral Thesis
unige:118259 
 |
Arginase 2 as a metabolic immune checkpoint in anti-tumor immunity |
|
| Author | ||
| Director | ||
| Defense | Thèse de doctorat : Univ. Genève, 2019 - Sc. Vie - Bioméd. 11 - 2019/03/21 | |
| Abstract | Arginine depletion, an essential amino acid for T cells, is a major immunosuppressive mechanism for anti-tumoral T cells. Despite extensive characterisation of extracellular arginine depletion by the arginase enzyme Arg1, the role of the more ancestral Arg2 isoform in immunity, and especially in anti-tumor immunity, remained unaddressed. Preclinical murine melanoma and colorectal carcinoma models showed that, while Arg2-overexpression in tumor cells impaired adaptive anti-tumor responses, germ-line and CD8+ T cell-specific Arg2 deletion enhanced anti-tumor immune responses, reducing tumor growth. Notably, combination of Arg2 deletion and PD-1 blockade synergistically improved single-immunotherapy effects. Concomitantly, we also engineered a new mouse strain (Arg2em1Wreith), a tool for further comprehension of Arg2 post-transcriptional regulation by the immunorelevant microRNA-155. In conjunction with incipient data on human ARG2 inhibition in T cells, this thesis proposes Arg2 as a new molecular target for the improvement of T cell-based immunotherapies, at the forefront of cancer treatments in modern medicine. | |
| Keywords | Immunology — Tumor — Cancer — Arginine — Arginase — Immunometabolism — Immunotherapy — CD8 T cells — Anti-tumor — PD-1 — Arg2 — Arginase 2 — Arg-II | |
| Identifiers | URN: urn:nbn:ch:unige-1182598 | |
| Full text | ||
| Structures | ||
| Research group | Groupe Reith Walter (pathologie et immunologie) (282) | |
| Citation (ISO format) | MARTI LINDEZ, Adria-Arnau. Arginase 2 as a metabolic immune checkpoint in anti-tumor immunity. Université de Genève. Thèse, 2019. doi: 10.13097/archive-ouverte/unige:118259 https://archive-ouverte.unige.ch/unige:118259 |
300 hits 
55 downloads 
Contact an author
Update